Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mylan
Mylan
Teva aims for 25% of U.S. EpiPen market by 2020
Drug Delivery Business News
Tue, 02/19/19 - 10:22 am
Teva Pharmaceutical
Mylan
EpiPen
generics
Mylan launches Advair generic at 70% discount in US
Pharmaforum
Wed, 02/13/19 - 10:13 am
Mylan
GSK
Advair
generics
Mylan takes step toward knocking down key patent for Biogen's top-seller
Biopharma Dive
Thu, 02/7/19 - 03:26 pm
Mylan
Biogen
Tecfidera
patents
inter partes review
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Tue, 02/5/19 - 10:03 am
Mylan
GSK
Advair
generics
FDA
asthma
Wixela Inhub
Mylan finally crosses the finish line with long-awaited generic of GlaxoSmithKline's Advair
Fierce Pharma
Wed, 01/30/19 - 06:58 pm
Mylan
GSK
FDA
Advair
generics
Wixela Inhub
UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing
Fierce Pharma
Tue, 01/22/19 - 11:48 am
UnitedHealthcare
generics
price fixing
drug pricing
Mylan
Teva Pharmaceuticals
Sandoz
Actavis
Par Pharmaceutical
Sun Pharma
Aurobindo
Taro Pharmaceuticals
Adamis stock surges on release of EpiPen alternative
Marketwatch
Thu, 01/17/19 - 09:34 am
Adamis
Mylan
Sandoz
EpiPens
Symjepi
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Thu, 01/3/19 - 09:40 am
Ironwood Pharmaceuticals
Mylan
patents
Linzess
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:37 pm
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Teva launches EpiPen generic at same price as Mylan's version
Biopharma Dive
Wed, 11/28/18 - 11:52 am
Teva Pharmaceutical
Mylan
EpiPens
generics
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Mylan, Theravance win FDA approval for COPD drug
Biopharma Dive
Mon, 11/12/18 - 11:37 pm
Theravance
Mylan
Yupelri
COPD
FDA
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Motley Fool
Tue, 11/6/18 - 11:33 am
Mylan
earnings
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Coherus
Neulasta
Mylan
biosimilars
Amgen
Early November Brings More Quarterly Reports
BioSpace
Sun, 11/4/18 - 02:38 pm
earnings
Akcea
Mylan
Eli Lilly
Regeneron
Momenta starts countdown to biosimilars exit
EP Vantage
Mon, 10/1/18 - 02:55 pm
Momenta Pharmaceuticals
Mylan
biosimilars
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Fri, 09/21/18 - 12:06 am
Europe
biosimilars
AbbVie
Humira
Mylan
Hulio
FDA extends EpiPen expiration date to ease shortages
Biopharma Dive
Wed, 08/22/18 - 11:47 am
Mylan
drug shortages
FDA
EpiPens
Mylan's EpiPen supply woes drag on
Biopharma Dive
Fri, 08/17/18 - 09:36 am
Mylan
Pfizer
EpiPens
drug shortages
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
Thu, 08/16/18 - 06:45 pm
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »